Fundz

ReAlta Life Sciences closes an oversubscribed $40 million financing round to advance their Phase 2 program for pegtarazimod in HIE.

PRIVATEApr 08, 2026

Amount Raised

$40 Million

Round Type

Funding Round

NorfolkBiotechnologyHealthcareHealth Care

Description

ReAlta Life Sciences has announced the closing of an oversubscribed $40 million financing round. The proceeds will support the development of pegtarazimod, targeting clinical and regulatory milestones for treating Hypoxic Ischemic Encephalopathy. The company's total capital raised now exceeds $150 million. They aim to complete the Phase 2 STAR trial and hold an End-of-Phase 2 meeting with the FDA.

Quick answer

ReAlta Life Sciences raised $40 Million in a Funding Round round, dated April 8, 2026. ReAlta Life Sciences is based in Norfolk, Virginia, United States.

How much did ReAlta Life Sciences raise?
ReAlta Life Sciences raised $40 Million in a Funding Round round on April 8, 2026.
What does ReAlta Life Sciences do?
ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases.
Where is ReAlta Life Sciences based and how big is it?
ReAlta Life Sciences is based in Norfolk, Virginia, United States. Fundz records about 31 employees.
Who are the decision-makers at ReAlta Life Sciences?
Fundz holds 1 contact at ReAlta Life Sciences, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as ReAlta Life Sciences that raised within 45 days of this round, from Fundz verified event records.

  • AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
  • IRulya Therapeutics Inc. raised $115M on May 18, 2026.
  • iSpecimen raised $5M (Post-IPO Equity) on May 11, 2026.
  • NewcelX raised $3.4M on April 27, 2026.
  • Enveric Biosciences raised $5M on April 17, 2026.
  • Athos Therapeutics, Inc. raised $10M on April 17, 2026.

Who to call at ReAlta Life Sciences, and when

A new round usually means ReAlta Life Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ReAlta Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ReAlta Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ReAlta Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ReAlta Life Sciences

Location

5665 LOWERY ROAD, SUITE 100

Norfolk, Virginia, United States

About

ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases. ReAlta’s EPICC peptides are based on research into the human astrovirus, HAstV-1, which causes a non-inflammatory, self-limiting gastroenteritis unique among viruses by inhibiting components of the innate immune system. ReAlta’s therapeutic peptides leverage these virus-derived mechanisms to rebalance complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has received IND clearance by the U.S. Food and Drug Administration (FDA) for the treatment of acute exacerbations of chronic obstructive pulmonary disease and acute graft-versus-host disease, and IND clearance, Orphan Drug Designation, and Fast Track Designation by the FDA, and Orphan Drug Designation by the European Medicines Agency, for the treatment of hypoxic-ischemic encephalopathy (HIE). The company launched in 2018, and is located in Norfolk, Virginia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ReAlta Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNeel K., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ReAlta Life Sciences's next move

See what Strategic adds

ReAlta Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.